347 related articles for article (PubMed ID: 12523370)
1. Access to affordable HIV/AIDS drugs: the human rights obligations of multinational pharmaceutical corporations.
Ferreira L
Fordham Law Rev; 2002 Dec; 71(3):1133-79. PubMed ID: 12523370
[No Abstract] [Full Text] [Related]
2. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
Spectar JM
Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
[No Abstract] [Full Text] [Related]
3. Pills, patents, and power: state creation of gray markets as a limit on patent rights.
Ghosh S
Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138
[No Abstract] [Full Text] [Related]
4. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
Joni J
Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
[No Abstract] [Full Text] [Related]
5. Introduction: Access to life-saving medicines and intellectual property rights.
Schroeder D
Camb Q Healthc Ethics; 2011 Apr; 20(2):277-8. PubMed ID: 21435302
[No Abstract] [Full Text] [Related]
6. International intellectual property, access to health care, and human rights: South Africa v. United States.
Nagan WP
Fla J Int Law; 2002; 14(2):155-91. PubMed ID: 16526137
[No Abstract] [Full Text] [Related]
7. Rights, patents, markets and the global AIDS pandemic.
Gathii JT
Fla J Int Law; 2002; 14(2):261-352. PubMed ID: 16526139
[No Abstract] [Full Text] [Related]
8. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
Curti AM
Am J Law Med; 2001; 27(4):469-85. PubMed ID: 11837145
[No Abstract] [Full Text] [Related]
9. Public health. HIV/AIDS treatment for millions.
Binswanger HP
Science; 2001 Apr; 292(5515):221-3. PubMed ID: 11305311
[No Abstract] [Full Text] [Related]
10. [Essential medicines and the TRIPS Agreement: collision between the right to health and intellectual property rights].
Allard Soto R
Salud Colect; 2015 Mar; 11(1):9-21. PubMed ID: 25853827
[TBL] [Abstract][Full Text] [Related]
11. Access to AIDS treatment in developing countries: a global issue of equity and human rights.
Thomas J
AIDS Anal Asia; 1998 Mar; 4(2):2-4. PubMed ID: 11657713
[No Abstract] [Full Text] [Related]
12. Ethics and AIDS drugs: some countries want to suspend patent and trade laws to get lower-cost medications to the poor.
Dowell W
Time; 1999 Jul; 152(4):49. PubMed ID: 11657653
[No Abstract] [Full Text] [Related]
13. Access to essential drugs, human rights and global justice.
Shalev C
Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
[No Abstract] [Full Text] [Related]
14. Companies to cut cost of AIDS drugs for poor nations.
McNeil DG
N Y Times Web; 2000 May; ():A1,4. PubMed ID: 11873792
[No Abstract] [Full Text] [Related]
15. In the high court of South Africa, case no. 4138/98: the global politics of access to low-cost AIDS drugs in poor countries.
Barnard D
Kennedy Inst Ethics J; 2002 Jun; 12(2):159-74. PubMed ID: 12476916
[TBL] [Abstract][Full Text] [Related]
16. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
Berger JM
Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
[No Abstract] [Full Text] [Related]
17. Gore under fire in controversy over South Africa AIDS drug law.
Wadman M
Nature; 1999 Jun; 399(6738):717-8. PubMed ID: 10391225
[No Abstract] [Full Text] [Related]
18. Affordable antiretroviral drugs for the under-served markets: how to expand equitable access against the backdrop of challenging scenarios?
Dionisio D; Cao Y; Hongzhou L; Kraisintu K; Messeri D
Curr HIV Res; 2006 Jan; 4(1):3-20. PubMed ID: 16454707
[TBL] [Abstract][Full Text] [Related]
19. International patent protection for HIV-related therapies: patent attorney's perspective.
Pavento LC; Greene JL; McDonald JK
Emory Int Law Rev; 2003; 17(2):919-31. PubMed ID: 15199935
[No Abstract] [Full Text] [Related]
20. Balancing pills and patents: intellectual property and the HIV/AIDS crisis.
Nderitu T
E Law; 2001 Sep; 8(3):E5. PubMed ID: 16903022
[No Abstract] [Full Text] [Related]
[Next] [New Search]
